BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17442731)

  • 1. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
    Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
    FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.
    Hart ML; Gorzolla IC; Schittenhelm J; Robson SC; Eltzschig HK
    J Immunol; 2010 Apr; 184(7):4017-24. PubMed ID: 20207994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
    Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Differential Effect of Apyrase Treatment and hCD39 Overexpression on Chronic Renal Fibrosis After Ischemia-Reperfusion Injury.
    Roberts V; Campbell DJ; Lu B; Chia J; Cowan PJ; Dwyer KM
    Transplantation; 2017 Jul; 101(7):e194-e204. PubMed ID: 28198766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
    Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
    J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
    Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
    FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of purinergic signaling on renal ischemia-reperfusion injury.
    Lu B; Rajakumar SV; Robson SC; Lee EK; Crikis S; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2008 Dec; 86(12):1707-12. PubMed ID: 19104409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a hanging-weight system for isolated renal artery occlusion during ischemic preconditioning in mice.
    Grenz A; Eckle T; Zhang H; Huang DY; Wehrmann M; Köhle C; Unertl K; Osswald H; Eltzschig HK
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F475-85. PubMed ID: 16912063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency or inhibition of CD73 protects in mild kidney ischemia-reperfusion injury.
    Rajakumar SV; Lu B; Crikis S; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
    Transplantation; 2010 Dec; 90(12):1260-4. PubMed ID: 21063242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning.
    Yamasowa H; Shimizu S; Inoue T; Takaoka M; Matsumura Y
    J Pharmacol Exp Ther; 2005 Jan; 312(1):153-9. PubMed ID: 15308652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning.
    Hart ML; Much C; Gorzolla IC; Schittenhelm J; Kloor D; Stahl GL; Eltzschig HK
    Gastroenterology; 2008 Nov; 135(5):1739-1750.e3. PubMed ID: 18804111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin-dependent kinase inhibitor p21 is essential for the beneficial effects of renal ischemic preconditioning on renal ischemia/reperfusion injury in mice.
    Nishioka S; Nakano D; Kitada K; Sofue T; Ohsaki H; Moriwaki K; Hara T; Ohmori K; Kohno M; Nishiyama A
    Kidney Int; 2014 Apr; 85(4):871-9. PubMed ID: 24336034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
    Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
    Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling.
    Kishore BK; Isaac J; Fausther M; Tripp SR; Shi H; Gill PS; Braun N; Zimmermann H; Sévigny J; Robson SC
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1032-43. PubMed ID: 15632415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury.
    Eckle T; Füllbier L; Wehrmann M; Khoury J; Mittelbronn M; Ibla J; Rosenberger P; Eltzschig HK
    J Immunol; 2007 Jun; 178(12):8127-37. PubMed ID: 17548651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
    Atkinson B; Dwyer K; Enjyoji K; Robson SC
    Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferulic Acid Protected from Kidney Ischemia Reperfusion Injury in Mice: Possible Mechanism Through Increasing Adenosine Generation via HIF-1α.
    Zhou Q; Gong X; Kuang G; Jiang R; Xie T; Tie H; Chen X; Li K; Wan J; Wang B
    Inflammation; 2018 Dec; 41(6):2068-2078. PubMed ID: 30143933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice.
    Joo JD; Kim M; D'Agati VD; Lee HT
    J Am Soc Nephrol; 2006 Nov; 17(11):3115-23. PubMed ID: 16988058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
    Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.